The outcomes of patients with hypoplastic left heart syndrome treated with the Norwood procedure over 2 consecutive surgical eras (1996 to 2002 and 2002 to 2005) were evaluated. Survival in the early postoperative period and at 2 years of age demonstrated improvement. Neurodevelopmental outcomes at 2 years of age (mental and psychomotor developmental indices) showed improvement in the more recent era, with psychomotor delay decreasing by half. For these outcomes, we have identified independent predictors, including modifiable variables, that may be important in guiding clinical care management. For survival outcome at 2 years of age, postoperative lactate was identified as an independent predictor, which supports the longstanding clinical practice aimed at optimizing patient hemodynamic status. For neurodevelopmental outcomes, the identified independent negative predictors included prolonged hospitalization and preoperative ventilation. We also identified other independent outcome predictors that may play an important role in parental counseling on anticipated neurodevelopmental outcome. Such findings may allow the clinician to tailor parent counseling by considering specific patient characteristics, such as the need for cardiopulmonary resuscitation, as well as sex and the family's socioeconomic status. Finally, early intervention and close multidisciplinary follow-up are instrumental for these children at risk for adverse neurodevelopmental outcomes. See p 1410.
Patent Foramen Ovale and Migraine: A Cross-Sectional Study From the Northern Manhattan Study (NOMAS)
Although a causal relationship between patent foramen ovale (PFO) and migraine has been hypothesized, and improvement of migraine severity after percutaneous PFO closure has been reported, population-based data on this relationship are sparse. This study reports on the lack of a significant association between migraine and PFO detected with transthoracic echocardiography and agitated saline among 1101 stroke-free elderly individuals derived from an urban, population-based, multiethnic cohort. In this population, the prevalence of self-reported migraine was 16% (13% migraine with aura); the prevalence of PFO was 15%, and 2% of all individuals had migraine and PFO. Migraine was significantly more frequent among younger individuals, women, and Hispanics. The observed lack of association between PFO and migraine (with or without aura) was not modified by other traditional risk factors such as diabetes mellitus, hypertension, cigarette smoking, or dyslipidemia. This study demonstrates that PFO and migraine are relatively frequent conditions in the general population, but their coexistence in an individual is uncommon. Although this study did not evaluate the effect of PFO closure, it indirectly supports the notion that the role of PFO closure among patients with refractory migraine is questionable, because a "true" relationship between PFO and migraine remains uncertain. See p 1419.
Pilot Trial on Determinants of Progenitor Cell Recruitment to the Infarcted Human Myocardium
This study investigates homing of radioactively labeled circulating progenitor cells into the infarct territory after intracoronary infusion into the infarct-related artery in patients after myocardial infarction. The salient findings are that the temporal proximity to the ischemic event, the extent of myocardial necrosis, and the magnitude of functional impairment of the coronary microcirculation are individually likely to determine an increased uptake and short-term retention of progenitor cells administered into the infarct-related coronary artery. These findings may indicate that the inflammatory processes ignited by the infarcted and necrotic myocardium may play a major role in the recruitment of progenitor cells into the ischemic tissue. Consequently, when the inflammatory activation of the coronary vasculature subsides during infarct healing and scar formation, recruitment and homing of intravascularly administered progenitor cells may be reduced. See p 1425.
Transition From Chronic Compensated to Acute Decompensated Heart Failure: Pathophysiological Insights Obtained From Continuous Monitoring of Intracardiac Pressures
The purpose of this study was to examine the pathophysiology of chronic compensated and acute decompensated heart failure (HF) in patients with systolic HF (SHF) versus patients with diastolic HF (DHF). In this study, continuous measurements of intracardiac pressures were made during periods of compensation, during the development of acute decompensation, and after effective treatment returned patients to a compensated state. This study showed that significant structural and functional differences exist between patients with SHF and those with DHF. However, elevated diastolic filling pressures play a pivotal role in the underlying pathophysiology of chronic compensated HF in both SHF and DHF. Acute decompensation in both DHF and SHF patients was preceded by a significant increase in diastolic pressures, which occurred Ͼ2 weeks before hospitalization for HF. In contrast, the patients who did not develop acute decompensated HF had no significant changes in diastolic filling pressures. In addition, effective treatment of acute decompensated HF resulted in improved diastolic filling pressures. Intracardiac hemodynamic monitoring may prove to be helpful in preventing and treating acute decompensated HF. Therefore, an increased understanding of the underlying pathophysiology of chronic compensated and acute decompensated HF in both SHF and DHF should allow us to develop more effective treatment and prevention strategies for all HF patients. See p 1433.
Cerebrovascular Thromboprophylaxis in Mice by Erythrocyte-Coupled Tissue-Type Plasminogen Activator
Cerebrovascular thrombosis is a major cause of mortality and morbidity, including after surgery when the use of thromboprophylaxis is limited by the formidable risk of perioperative bleeding. Nor can thrombolytics (eg, tissue-type plasminogen activator [tPA]) be used prophylactically in this and other high-risk settings because of their short duration of action and risk of causing hemorrhage. Coupling tPA to red blood cells (RBCs) prolongs and confines activity within the bloodstream and enhances resistance to plasma inhibitors, thereby providing a novel thromboprophylactic agent, RBC/tPA. Our results indicate that injection of RBC/tPA into mice before thromboembolic occlusion of the middle carotid artery facilitates clot lysis, assists in rapid and stable cerebrovascular reperfusion, alleviates ischemic brain damage, and eliminates mortality, whereas pretreatment with tPA is not protective even at a 10-fold higher dose at which mortality is aggravated. At protective doses, RBC/tPA did not consume plasma fibrinogen or cause postsurgical bleeding or hemorrhage and toxicity in the central nervous system in rodent models of brain ischemia and thrombosis. These animal studies indicate that RBC/tPA might provide thromboprophylaxis in patients at risk for cerebrovascular thromboembolism in the postoperative period; after transient ischemic attack, myocardial infarction, and stroke; or in the setting of non-STelevation acute myocardial infarction, which is characterized by multiple cycles of intravascular rethrombosis and incomplete thrombolysis. Nascent and growing occlusive clots represent the preferable target for RBC/tPA. Use of injectable antithrombotic prodrugs conjugated with RBC binding peptides may further enhance the clinical application of this new approach toward prophylactic thrombolysis within the cerebral and other vasculatures. See p 1442.
Activation of Liver X Receptors Promotes Neuroprotection and Reduces Brain Inflammation in Experimental Stroke
Liver X receptors (LXRs) ␣ and ␤ are ligand-activated transcription factors that belong to the nuclear receptor superfamily. LXRs regulate the expression of a number of genes involved in cholesterol metabolism. In addition, LXRs are known to antagonize the expression of a panel of inflammatory genes. All these pieces of evidence suggest that LXR activation may exert a protective role in pathologies in which inflammation is involved such as stroke. Taking into account the epidemiological importance of stroke and the limited possibilities for treatment, activation of LXR might arise as a possible powerful approach for stroke treatment. The present results demonstrate that the activation of the LXR receptors exerts potent neuroprotective actions in experimental stroke, which are concomitant to the inhibition of inflammatory mediators. Apart from the possible therapeutic repercussions in acute stroke management, these findings suggest, on one hand, that the endogenous levels of LXR agonists such as oxysterols could serve as a helpful prognostic marker in stroke patients and, on the other, that polymorphisms or other alterations of the LXR receptor expression or function may increase vulnerability to stroke. See p 1450.
Aortic Valve Bypass Surgery: Midterm Clinical Outcomes in a High-Risk Aortic Stenosis Population
Recent recognition that a large number of symptomatic patients with aortic stenosis (AS) are not referred for surgery as a result of real and perceived risks of conventional aortic valve replacement has sparked interest in alternative therapies. Aortic valve bypass (AVB; apicoaortic conduit) surgery relieves AS by shunting blood from the apex of the left ventricle to the descending thoracic aorta through a valved conduit. AVB surgery has been performed, albeit uncommonly, for Ͼ45 years. The aim of this study was to characterize outcomes in a series of very high-risk AS patients treated with AVB surgery. A total of 31 patients underwent AVB surgery. In all cases, the heart was beating, and no ascending aortic manipulation was necessary. Cardiopulmonary bypass was used briefly in 61% of patients and has been used less commonly as experience has been gained in performing AVB surgery on the beating heart. Echocardiographic analyses demonstrated that AVB surgery was effective at relieving the outflow obstruction associated with valvular AS, that blood flow was predictably distributed between the conduit and native left ventricular outflow tract, and that left ventricular performance was preserved after surgery. Stroke and renal dysfunction were uncommon after AVB surgery. This experience suggests that AVB surgery is an important therapeutic option for the high-risk AS patient. Continued improvements in technology and surgical technique may warrant extending AVB surgery to moderate-risk AS patients. See p 1460.
Inhibition of Stearoyl-Coenzyme A Desaturase 1 Dissociates Insulin Resistance and Obesity From Atherosclerosis
The metabolic syndrome has become a leading health concern in developed countries. Importantly, the presence of the metabolic syndrome has been shown to be a predictor of atherosclerotic cardiovascular disease extent in humans. Simply by catalyzing the conversion of long-chain saturated fatty acids to monounsaturated fatty acids, stearoyl-coenzyme A desaturase 1 (SCD1) has been shown to promote multiple aspects of the metabolic syndrome. Therefore, inhibition of SCD1 is currently regarded as a promising therapeutic strategy, yet little information exists on whether SCD1 inhibition could also protect against atherosclerosis. To examine this possibility, we inhibited SCD1 in a hyperlipidemic mouse model of atherosclerosis. In agreement with previous reports, inhibition of SCD1 protected against diet-induced obesity, insulin resistance, hypertriglyceridemia, and hepatic steatosis. However, quite unexpectedly, SCD1 inhibition strongly promoted aortic atherosclerosis. Because dietary saturated fatty acids have been shown to promote inflammation through toll-like receptor 4, we examined macrophage toll-like receptor 4 function. Interestingly, SCD1 inhibition resulted in marked hypersensitivity to toll-like receptor 4 agonists in macrophages. This study is the first to report the consequences of inhibiting SCD1 on atherosclerosis. Although the presence of the metabolic syndrome may be associated with atherosclerosis in humans, this study provides evidence that the metabolic syndrome can be completely dissociated from atherosclerosis in mice. Taken together, these results suggest that the link between obesity and systemic insulin resistance and atherosclerosis should be approached with caution and that SCD1 inhibition may not necessarily be a treatment for atherosclerosis and its complications. See p 1467.
